A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma.
暂无分享，去创建一个
P. Thall | S. Parmar | E. Shpall | R. Orlowski | Y. Nieto | U. Popat | Q. Bashir | M. Qazilbash | R. Champlin | M. de Lima | J. Shah | S. Giralt | G. Rondón | C. Hosing | P. Kebriaei | B. Oran | S. Ciurea | N. Shah | Roy W. Jones | Ping Liu | Y. Dinh | Hassan Khan | Roy B. Jones | G. Rondon